Also trades as: OABIW (NASDAQ) · $vol 0M
OABI NASDAQ
OmniAb, Inc.
1W: +16.4%
1M: +70.0%
3M: +50.0%
YTD: +35.6%
1Y: +65.6%
3Y: -33.4%
$2.65
+0.10 (+3.92%)
Weekly Expected Move ±11.9%
$2
$2
$2
$2
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (15)
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
OmniAb (OABI) Q1 2026 Earnings Transcript
OmniAb forecasts $28M-$33M 2026 revenue as partner milestones lift outlook
OmniAb, Inc. (OABI) Reports Q1 Loss, Tops Revenue Estimates
USANA Health Sciences (USNA) Q1 Earnings and Revenues Surpass Estimates
OmniAb (OABI) Q4 2025 Earnings Call Transcript
OmniAb outlines $25M–$30M 2026 revenue guidance as partner pipeline accelerates with OmniUltra and xPloration launches
OmniAb, Inc. (OABI) Reports Q4 Loss, Misses Revenue Estimates
OmniAb GAAP EPS of -$0.11 misses by $0.02, revenue of $8.4M misses by $0.6M
OmniAb Q4 Earnings Assessment
Earnings Scheduled For March 4, 2026
A Look Ahead: OmniAb's Earnings Forecast
OmniAb, Inc. (OABI) Discusses Launch and Scientific Overview of OmniUltra Technology Platform Transcript
Launch of OmniUltra Expands OmniAb's Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies
OmniAb to Hold OmniUltra Virtual Investor Event on December 15